Fenretinide in Treating Patients With Solid Tumors

NCT00003250 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

31

Enrollment

OTHER

Sponsor class

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: fenretinide

Sponsor

Barbara Ann Karmanos Cancer Institute

Collaborators

[object Object]